US Patent

US8627816 — Medicament delivery device for administration of opioid antagonists including formulations for naloxone

Formulation · Assigned to Intelliject Inc · Expires 2032-02-04 · 6y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a medicament delivery device for administering opioid antagonists, including a specific formulation of naloxone.

USPTO Abstract

Medicament delivery devices for administration of opioid antagonists are described herein. In some embodiments, an apparatus includes a housing, a medicament container disposed within the housing and an energy storage member disposed within the housing. The medicament container is filled with a naloxone composition that includes naloxone or salts thereof, a tonicity-adjusting agent, and a pH adjusting agent, whereby the osmolality of the naloxone composition ranges from about 250-350 mOsm and the pH ranges from about 3-5. The energy storage member is configured to produce a force to deliver the naloxone composition.

Drugs covered by this patent

Patent Metadata

Patent number
US8627816
Jurisdiction
US
Classification
Formulation
Expires
2032-02-04
Drug substance claim
No
Drug product claim
Yes
Assignee
Intelliject Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.